Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01665521 · ClinicalTrials.gov registry record · NA
Efficacy Evaluation of the HEART Pathway in Emergency Department Patients With Acute Chest Pain
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 282
- Enrollment target
NCT01665521 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 282 participants.
The verdict
NCT01665521, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 282 participants
- Enrollment target
Study Summary
Our research will examine a chest pain care strategy, called the HEART pathway, which is designed to correctly identify Emergency Department patients at high-risk for cardiovascular events, likely to benefit from further testing, and patients at very-low-risk for cardiovascular events, who may be safely discharged home. By using an individual's risk assessment to determining testing, we hope to improve the quality and efficiency of the care delivered to Emergency Department patients with chest pain. Our study will determine if the HEART pathway, which combines a clinical decision rule, the HEART score, and two serial troponin measurements, will reduce stress testing and cardiovascular imaging, decrease hospital length of stay, and reduce cost compared to usual care, while maintaining safety.
Interventions
- OTHER HEART Pathway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 282 participants |
| Start Date | 2012-09 |
| Est. Completion | 2018-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01665521
The ClinicalTrials.gov registry entry for NCT01665521 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 282 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HEART Pathway is the first listed.
NCT01665521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01665521 about?
NCT01665521 is a clinical study titled "Efficacy Evaluation of the HEART Pathway in Emergency Department Patients With Acute Chest Pain". Our research will examine a chest pain care strategy, called the HEART pathway, which is designed to correctly identify Emergency Department patients at high-risk for cardiovascular events, likely to benefit from further testing, and patients at very-low-risk for cardiovascular events, who may be sa...
What is the current status of trial NCT01665521?
This trial is currently completed. It is a NA study. The enrollment target is 282 participants. The study started on 2012-09. Estimated completion is 2018-01-15.
What interventions are being tested in trial NCT01665521?
The interventions under investigation include: HEART Pathway (OTHER).
Who is sponsoring clinical trial NCT01665521?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.